CNS Oncology (Dec 2018)

Distribution of tumor-infiltrating immune cells in glioblastoma

  • Enrique Orrego,
  • Carlos A Castaneda,
  • Miluska Castillo,
  • Luis A Bernabe,
  • Sandro Casavilca,
  • Arnab Chakravarti,
  • Wei Meng,
  • Pamela Garcia-Corrochano,
  • Maria R Villa-Robles,
  • Rocio Zevallos,
  • Omar Mejia,
  • Pedro Deza,
  • Carolina Belmar-Lopez,
  • Luis Ojeda

DOI
https://doi.org/10.2217/cns-2017-0037
Journal volume & issue
Vol. 7, no. 4

Abstract

Read online

Aim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. Results: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4+ was associated with unmethylated MGMT (p = 0.016). Higher CD8+ was associated with larger tumoral size (p = 0.027). Higher CD163+ was associated with higher age (p = 0.044) and recursive partitioning analysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4+ (p < 0.05) were associated with longer overall survival. Conclusion: Macrophages are more frequent than TILs. Some subsets are associated with clinical features.

Keywords